Yep, granted they need to spend money (our money) to get product recognition and market penetration. But at some point at this phase in the company's growth, the revenue will need to grow faster than the staff costs (the inverse is currently occurring thus the sad state of the SP).
This used to be a speculative stock but I suspect many have left (and will continue to leave) when it becomes apparent this is a slow-burn operation. At the start of this year, I was hoping for 20c by end of year and now I'm hoping for 10c. Even long term holders will start to exit if the company looks like its burn rate will require CR's every year. Not good enough for a company with product/s on the market.
On a positive note, I dont see the SP going below 7c so I think we're at a fairly safe bottom (famous last words).
- Forums
- ASX - By Stock
- AVR
- Quarterly
Quarterly, page-118
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online